Geode Capital Management
WST icon

Geode Capital Management’s West Pharmaceutical WST Stock Holding History

Geode Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478M Buy
1,912,455
+43,369
+2% +$10.8M 0.03% 455
2025
Q4 		$512M Buy
1,869,086
+11,962
+0.6% +$3.27M 0.03% 434
2025
Q3 		$485M Buy
1,857,124
+24,120
+1% +$5.86M 0.03% 436
2025
Q2 		$399M Sell
1,833,004
-20,689
-1% -$4.42M 0.03% 462
2025
Q1 		$414M Buy
1,853,693
+74,753
+4% +$20.6M 0.03% 436
2024
Q4 		$581M Buy
1,778,940
+38,757
+2% +$12.2M 0.05% 349
2024
Q3 		$521M Buy
1,740,183
+12,850
+0.7% +$3.94M 0.04% 366
2024
Q2 		$567M Buy
1,727,333
+9,937
+0.6% +$3.51M 0.05% 324
2024
Q1 		$678M Buy
1,717,396
+49,349
+3% +$18.3M 0.06% 289
2023
Q4 		$586M Buy
1,668,047
+49,578
+3% +$17.5M 0.06% 295
2023
Q3 		$606M Buy
1,618,469
+27,971
+2% +$10.8M 0.07% 261
2023
Q2 		$607M Buy
1,590,498
+48,047
+3% +$17.2M 0.07% 266
2023
Q1 		$533M Buy
1,542,451
+35,627
+2% +$10.4M 0.07% 285
2022
Q4 		$354M Buy
1,506,824
+36,935
+3% +$8.75M 0.05% 364
2022
Q3 		$361M Buy
1,469,889
+28,366
+2% +$8.64M 0.05% 338
2022
Q2 		$435M Buy
1,441,523
+12,437
+0.9% +$4.05M 0.06% 295
2022
Q1 		$586M Buy
1,429,086
+47,070
+3% +$18.4M 0.07% 266
2021
Q4 		$647M Buy
1,382,016
+40,280
+3% +$17.3M 0.08% 248
2021
Q3 		$568M Buy
1,341,736
+42,648
+3% +$18M 0.08% 251
2021
Q2 		$465M Buy
1,299,088
+540
+0% +$178K 0.06% 302
2021
Q1 		$365M Buy
1,298,548
+41,626
+3% +$11.9M 0.06% 338
2020
Q4 		$355M Buy
1,256,922
+38,512
+3% +$10.8M 0.06% 312
2020
Q3 		$334M Buy
1,218,410
+10,881
+0.9% +$2.88M 0.07% 277
2020
Q2 		$274M Buy
1,207,529
+269,961
+29% +$53M 0.06% 303
2020
Q1 		$143M Buy
937,568
+64,051
+7% +$9.86M 0.04% 412
2019
Q4 		$131M Buy
873,517
+43,022
+5% +$6.26M 0.03% 514
2019
Q3 		$118M Buy
830,495
+19,128
+2% +$2.63M 0.03% 518
2019
Q2 		$102M Sell
811,367
-2,074
-0.3% -$245K 0.02% 557
2019
Q1 		$89.6M Buy
813,441
+70,288
+9% +$7.31M 0.02% 580
2018
Q4 		$72.9M Buy
743,153
+73,058
+11% +$7.93M 0.02% 578
2018
Q3 		$82.7M Buy
670,095
+19,909
+3% +$2.23M 0.02% 581
2018
Q2 		$64.6M Buy
650,186
+38,689
+6% +$3.56M 0.02% 652
2018
Q1 		$54M Buy
611,497
+20,359
+3% +$1.9M 0.02% 698
2017
Q4 		$58.3M Buy
591,138
+12,420
+2% +$1.22M 0.02% 646
2017
Q3 		$55.7M Buy
578,718
+3,421
+0.6% +$310K 0.02% 629
2017
Q2 		$54.4M Buy
575,297
+26,634
+5% +$2.45M 0.02% 623
2017
Q1 		$44.8M Buy
548,663
+32,548
+6% +$2.72M 0.02% 688
2016
Q4 		$43.8M Buy
516,115
+18,315
+4% +$1.44M 0.02% 641
2016
Q3 		$37.1M Buy
497,800
+11,008
+2% +$874K 0.02% 673
2016
Q2 		$36.9M Buy
486,792
+6,951
+1% +$506K 0.02% 639
2016
Q1 		$33.3K Buy
479,841
+23,029
+5% +$1.39M 0.02% 673
2015
Q4 		$27.5M Buy
456,812
+20,033
+5% +$1.21M 0.02% 737
2015
Q3 		$23.6M Buy
436,779
+3,988
+0.9% +$232K 0.01% 792
2015
Q2 		$25.1M Buy
432,791
+24,896
+6% +$1.39M 0.01% 805
2015
Q1 		$24.6M Buy
407,895
+5,202
+1% +$277K 0.01% 805
2014
Q4 		$21.4M Buy
402,693
+12,363
+3% +$618K 0.01% 829
2014
Q3 		$17.5M Sell
390,330
-6,972
-2% -$296K 0.01% 898
2014
Q2 		$16.8M Sell
397,302
-45,967
-10% -$1.97M 0.01% 948
2014
Q1 		$19.5M Buy
443,269
+2,373
+0.5% +$112K 0.01% 834
2013
Q4 		$21.6M Buy
440,896
+91,882
+26% +$4.3M 0.02% 745
2013
Q3 		$14.4M Buy
349,014
+26,532
+8% +$1.01M 0.01% 856
2013
Q2 		$11.3M Buy
+322,482
New +$10.6M 0.01% 886

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management's WST Position: Q1 2026 in Review

Geode Capital Management increased its West Pharmaceutical (WST) stake by 2.3% in Q1 2026, buying an estimated $10.8M and bringing the position to 1,912,455 shares worth $478M. The position accounts for 0.03% of the portfolio, ranked #455.

Geode Capital Management first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $678M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Geode Capital Management held 1,912,455 shares of West Pharmaceutical worth $478M as of Q1 2026.
  • Geode Capital Management bought 43,369 West Pharmaceutical shares in Q1 2026, an estimated $10.8M.
  • West Pharmaceutical made up 0.03% of Geode Capital Management's portfolio in Q1 2026, its #455 holding.
  • Geode Capital Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's West Pharmaceutical position peaked at $678M in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.